CUBD Assists TearFilm Innovations Secure Investment

CUBD Assists TearFilm Innovations Secure Investment

Cincinnati, Ohio; Shenzhen, China: August 8, 2017: CUBD assisted Tear Film Innovations (TFI) an early-stage company developing a family of breakthrough products for the treatment of evaporative dry eye and related syndromes secure a portion of their Series A funding with a group of investors from a leading Chinese Investment firm led by Dr. Feng Jiang. Through a strategic partnership with Dr. Jiang, CUBD will assist TFI in their expansion into China.

About Tear Film Innovations (TFI): TFI is an early-stage company developing a family of break-through products for the treatment of evaporative dry eye and related syndromes including meibomian gland dysfunction (MGD) and blepharitis.TFI was founded by a team of experienced medical device engineers and eye care professionals, most of who suffer from some form of evaporative dry eye (EDE) and who were frustrated by the lack of effective treatment options. To address this important unmet need, TFI’s team has developed a family of products that attack the root causes of EDE and empower patients to take control of their own condition.

Back To Top